Your browser doesn't support javascript.
loading
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view.
Shirazi, Farshad M; Mirzaei, Roya; Nakhaee, Samaneh; Nejatian, Amir; Ghafari, Shokouh; Mehrpour, Omid.
Afiliação
  • Shirazi FM; Arizona Poison & Drug Information Center, College of Pharmacy and University of Arizona College of Medicine, University of Arizona, Tucson, AZ, USA.
  • Mirzaei R; Faculty of Pharmacy and Pharmaceutical Sciences, Islamic Azad University, Tehran Medical Sciences University (IAUTMU), Tehran, Iran.
  • Nakhaee S; Venom and Biotherapeutic Molecules Lab., Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, 13169-43551, Tehran, Iran.
  • Nejatian A; Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
  • Ghafari S; Department of Civil Eng., Sharif University of Technology, Tehran, Iran.
  • Mehrpour O; Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Eur J Med Res ; 27(1): 21, 2022 Feb 05.
Article em En | MEDLINE | ID: mdl-35123559
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ivermectina / Reposicionamento de Medicamentos / Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ivermectina / Reposicionamento de Medicamentos / Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article